To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JC-001 and JLP-1901
Clinical trial NCT06171880 · COMPLETED
Trial details
- NCT number
- NCT06171880
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2022-03-11
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.